U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07885982) titled 'Conditioning Regimen Containing Low-Dose ATG for the Treatment of AA Receiving sUCBT' on Aug. 20.
Brief Summary: To evaluate the safety and efficacy of Single Umbilical Cord blood transplantation (sUCBT) containing low dose ATG based conditioning regimen in the treatment of Aplastic Anemia (AA)
Study Start Date: Aug. 01, 2027
Study Type: INTERVENTIONAL
Condition:
Aplastic Anaemia
Intervention:
DRUG: Anti-Thymocyte Globulin (Rabbit) (Thymoglobulin(R))
Participants with aplastic anemia will receive a low-dose rabbit anti-thymocyte globulin (rATG)-containing conditioning regimen followed by single-unit umbilical cord blood trans...